PL369363A1 - Nadrozgałęziona amylopektyna do zastosowania w sposobach chirurgicznego lub terapeutycznego leczenia ssaków albo w sposobach diagnozowania, zwłaszczado zastosowania jako środek zwiększający objętośćosocza krwi - Google Patents

Nadrozgałęziona amylopektyna do zastosowania w sposobach chirurgicznego lub terapeutycznego leczenia ssaków albo w sposobach diagnozowania, zwłaszczado zastosowania jako środek zwiększający objętośćosocza krwi

Info

Publication number
PL369363A1
PL369363A1 PL02369363A PL36936302A PL369363A1 PL 369363 A1 PL369363 A1 PL 369363A1 PL 02369363 A PL02369363 A PL 02369363A PL 36936302 A PL36936302 A PL 36936302A PL 369363 A1 PL369363 A1 PL 369363A1
Authority
PL
Poland
Prior art keywords
methods
amylopectin
plasma volume
surgical
plasma
Prior art date
Application number
PL02369363A
Other languages
English (en)
Other versions
PL209763B1 (pl
Inventor
Klaus Sommermeyer
Original Assignee
Supramol Parenteral Colloids Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supramol Parenteral Colloids Gmbh filed Critical Supramol Parenteral Colloids Gmbh
Publication of PL369363A1 publication Critical patent/PL369363A1/pl
Publication of PL209763B1 publication Critical patent/PL209763B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/20—Amylose or amylopectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B35/00—Preparation of derivatives of amylopectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL369363A 2001-08-22 2002-08-06 Nadrozgałęziona amylopektyna i jej nadrozgałęzione pochodne PL209763B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10141099 2001-08-22

Publications (2)

Publication Number Publication Date
PL369363A1 true PL369363A1 (pl) 2005-04-18
PL209763B1 PL209763B1 (pl) 2011-10-31

Family

ID=7696220

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369363A PL209763B1 (pl) 2001-08-22 2002-08-06 Nadrozgałęziona amylopektyna i jej nadrozgałęzione pochodne

Country Status (19)

Country Link
US (1) US7393841B2 (pl)
EP (1) EP1421120B1 (pl)
JP (1) JP2005501930A (pl)
KR (1) KR100898528B1 (pl)
CN (1) CN100390203C (pl)
AT (1) ATE360651T1 (pl)
AU (1) AU2002325398B2 (pl)
CA (1) CA2456507C (pl)
DE (2) DE10235954A1 (pl)
DK (1) DK1421120T3 (pl)
ES (1) ES2283585T3 (pl)
HU (1) HUP0401188A3 (pl)
MX (1) MXPA04001606A (pl)
PL (1) PL209763B1 (pl)
PT (1) PT1421120E (pl)
RO (1) RO122279B1 (pl)
RS (1) RS51420B (pl)
RU (1) RU2303984C2 (pl)
WO (1) WO2003018639A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
DE10237442B4 (de) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Hochverzweigte, niedrig substituierte Stärkeprodukte
DE10256558A1 (de) * 2002-12-04 2004-09-16 Supramol Parenteral Colloids Gmbh Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
CZ20033424A3 (cs) * 2003-12-16 2005-08-17 Parenteral, A. S. Náhražka krevní plazmy, výchozí produkt a způsob výroby výchozího produktu pro náhražku lidské krevní plazmy
FR2864088B1 (fr) * 2003-12-19 2006-04-28 Roquette Freres Polymeres solubles de glucose hautement branches
CA2653541C (en) 2005-06-06 2014-12-23 The University Of British Columbia Polymer-based serum albumin substitute
EP1943908A1 (en) * 2006-12-29 2008-07-16 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Novel slowly digestible storage carbohydrate
EP2542613A4 (en) 2010-03-01 2013-12-11 Univ British Columbia SUBSTITUTED HYPERBRANCHED POLYGLYCEROLS
JP5669838B2 (ja) * 2010-06-17 2015-02-18 株式会社林原 プルラン含有粉末とその製造方法並びに用途
AR095937A1 (es) * 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA928215A (en) 1969-08-08 1973-06-12 M. Brake Jon Process for the cryogenic preservation of blood and erythrocytes and products produced thereby
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
US4111199A (en) * 1977-03-31 1978-09-05 Isaac Djerassi Method of collecting transfusable granulocytes by gravity leukopheresis
DE3029307A1 (de) 1980-08-01 1982-03-04 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Haemoglobin enthaltendes blutersatzmittel
US4454161A (en) * 1981-02-07 1984-06-12 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of branching enzyme, and a method for improving the qualities of food products therewith
DE3313600A1 (de) * 1983-04-14 1984-10-18 Laevosan-Gesellschaft mbH & Co. KG, Linz Plasmastreckmittel auf staerkebasis und verfahren zu ihrer herstellung
NL8902128A (nl) * 1989-08-23 1991-03-18 Avebe Coop Verkoop Prod Vertakkingsenzym en gebruik daarvan.
JP2896580B2 (ja) 1989-08-25 1999-05-31 チッソ株式会社 アミロース―リゾチームハイブリッドと活性化糖およびその製造法
RU2021283C1 (ru) * 1992-05-27 1994-10-15 Яровая Светлана Михайловна Способ получения фракции гидролизата оксиэтилированного крахмала для приготовления кровезаменителя противошокового действия
DE19628705A1 (de) 1996-07-08 1998-01-15 Fresenius Ag Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe
FR2783838B1 (fr) * 1998-09-25 2000-12-01 Roquette Freres Procede de preparation d'un melange d'enzymes de branchement de l'amidon extraites d'algues
AT409928B (de) * 1999-08-10 2002-12-27 Tulln Zuckerforschung Gmbh Plasmaexpander, blutverdünnungsmittel und kryoprotektor, hergestellt unter verwendung von amylopektin-kartoffelstärke
JP2001294601A (ja) 2000-04-11 2001-10-23 Akita Prefecture 高度分岐澱粉と該高度分岐澱粉の製造方法
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung

Also Published As

Publication number Publication date
AU2002325398B2 (en) 2008-02-28
CN1545522A (zh) 2004-11-10
HUP0401188A3 (en) 2012-09-28
PL209763B1 (pl) 2011-10-31
MXPA04001606A (es) 2005-03-07
RU2303984C2 (ru) 2007-08-10
JP2005501930A (ja) 2005-01-20
DE50210039D1 (de) 2007-06-06
HUP0401188A2 (hu) 2004-09-28
EP1421120A1 (de) 2004-05-26
PT1421120E (pt) 2007-08-03
ES2283585T3 (es) 2007-11-01
DE10235954A1 (de) 2003-03-06
US20040157207A1 (en) 2004-08-12
HK1068356A1 (zh) 2005-04-29
KR20040052215A (ko) 2004-06-22
CA2456507A1 (en) 2003-03-06
KR100898528B1 (ko) 2009-05-20
WO2003018639A1 (de) 2003-03-06
EP1421120B1 (de) 2007-04-25
CA2456507C (en) 2011-05-03
RS14704A (sr) 2007-02-05
RS51420B (sr) 2011-02-28
DK1421120T3 (da) 2007-09-17
ATE360651T1 (de) 2007-05-15
US7393841B2 (en) 2008-07-01
CN100390203C (zh) 2008-05-28
RO122279B1 (ro) 2009-03-30
RU2004108122A (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
WO1997029779A3 (en) EGF-Genistein conjugates for the treatment of cancer
WO2001068135A3 (en) Compositions and methods for affecting osteogenesis
IL139285A0 (en) Peg-lhrh analog conjugates, their preparation and use
EP2292649A3 (en) Therapeutic epitopes and uses thereof
WO2003022210A3 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
WO2003002022A3 (en) Minimally invasive orthopaedic apparatus and methods
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
WO2002060315A3 (en) Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
CA2253632A1 (en) Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
MXPA04001982A (es) Factor ix modificado.
WO2004039248A3 (en) Repairing or replacing tissues or organs
EP4252776A3 (en) Compositions and methods for treating ocular diseases
DK1421120T3 (da) Hyperforgrenet amylopektin til anvendelse ved metoder til kirurgisk eller terapeutisk behandling af pattedyr eller til diagnostiske metoder, især til anvendelse som midler til plasmavolumenekspansion
WO2001038303A3 (fr) Analogues de la vitamine d
HK1043546A1 (zh) 採用異黃酮類化合物治療心血管疾病和骨疾病
WO2025189056A8 (en) Heterobifunctional compounds and their use in treating disease
MXPA02012064A (es) Complejos de farmaco macromoleculares y composiciones que los contienen.
WO2001005408A8 (en) Fat-binding polymers, optionally combined with lipase inhibitors
WO2025189057A8 (en) Heterobifunctional compounds and methods of treating disease
EP2191839A3 (en) Immunogenic LHRH compositions and methods relating thereto
WO2001035995A3 (en) Tr3-specific binding agents and methods for their use
ATE237349T1 (en) Fat-binding polymers
MXPA04001976A (es) Hormona de crecimiento humano modificada.
AU2002325398A1 (en) Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
JPH1160499A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20130806